AAAAAA

   
Results: 1-16 |
Results: 16
Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study
Authors: Fahy, JV Boushey, HA Lazarus, SC Mauger, EA Cherniack, RM Chinchilli, VM Craig, TJ Drazen, JM Ford, JG Fish, JE Israel, E Kraft, M Lemanske, RF Martin, RJ McLean, D Peters, SP Sorkness, C Szefler, SJ
Citation: Jv. Fahy et al., Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study, AM J R CRIT, 163(6), 2001, pp. 1470-1475
Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle
Authors: Pascual, RM Billington, CK Hall, IP Panettieri, RA Fish, JE Peters, SP Penn, RB
Citation: Rm. Pascual et al., Mechanisms of cytokine effects on G protein-coupled receptor-mediated signaling in airway smooth muscle, AM J P-LUNG, 281(6), 2001, pp. L1425-L1435
Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma
Authors: Israel, E Drazen, JM Liggett, SB Boushey, HA Cherniack, RM Chinchilli, VM Cooper, DM Fahy, JV Fish, JE Ford, JG Kraft, M Kunselman, S Lazarus, SC Lemanske, RF Martin, RJ McLean, DE Peters, SP Silverman, EK Sorkness, CA Szefler, SJ Weiss, ST Yandava, CN
Citation: E. Israel et al., Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma, INT A AL IM, 124(1-3), 2001, pp. 183-186
Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial
Authors: Lazarus, SC Boushey, HA Fahy, JV Chinchilli, VM Lemanske, RF Sorkness, CA Kraft, M Fish, JE Peters, SP Craig, T Drazen, JM Ford, JG Israel, E Martin, RJ Mauger, EA Nachman, SA Spahn, JD Szefler, SJ
Citation: Sc. Lazarus et al., Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2583-2593
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial
Authors: Lemanske, RF Sorkness, CA Mauger, EA Lazarus, SC Boushey, HA Fahy, JV Drazen, JM Chinchilli, VM Craig, T Fish, JE Ford, JG Israel, E Kraft, M Martin, RJ Nachman, SA Peters, SP Spahn, JD Szefler, SJ
Citation: Rf. Lemanske et al., Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2594-2603
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy
Authors: Fish, JE Israel, E Murray, JJ Emmett, A Boone, R Yancey, SW Rickard, KA
Citation: Je. Fish et al., Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy, CHEST, 120(2), 2001, pp. 423-430
The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research
Authors: Leone, FT Mauger, EA Peters, SP Chinchilli, VM Fish, JE Boushey, HA Cherniack, RM Drazen, JM Fahy, JV Ford, J Israel, E Lazarus, SC Lemanske, RF Martin, RJ McGeady, SJ Sorkness, C Szefler, SJ
Citation: Ft. Leone et al., The utility of peak flow, symptom scores, and beta-agonist use as outcome measures in asthma clinical research, CHEST, 119(4), 2001, pp. 1027-1033
The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma
Authors: Israel, E Drazen, JM Liggett, SB Boushey, HA Cherniack, RM Chinchilli, VM Cooper, DM Fahy, JV Fish, JE Ford, JG Kraft, M Kunselman, S Lazarus, SC Lemanske, RF Martin, RJ McLean, DE Peters, SP Silverman, EK Sorkness, CA Szefler, SJ Weiss, ST Yandava, CN
Citation: E. Israel et al., The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma, AM J R CRIT, 162(1), 2000, pp. 75-80
Guidelines for methacholine and exercise challenge testing - 1999
Authors: Crapo, RO Casaburi, R Coates, AL Enright, PL Hankinson, JL Irvin, CG MacIntyre, NR McKay, RT Wanger, JS Anderson, SD Cockcroft, DW Fish, JE Sterk, PJ
Citation: Ro. Crapo et al., Guidelines for methacholine and exercise challenge testing - 1999, AM J R CRIT, 161(1), 2000, pp. 309-329
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related duality of life in patients with severe persistent asthma
Authors: Fish, JE Karpel, JP Craig, TJ Bensch, GW Noonan, M Webb, DR Silverman, B Schenkel, EJ Rooklin, AR Ramsdell, JW Nathan, R Leflein, JG Grossman, J Graft, DF Gower, RG Garay, SM Frigas, E DeGraff, AC Bronsky, EA Bernstein, DI Berger, W Shneyer, L Nolop, KB Harrison, JE
Citation: Je. Fish et al., Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related duality of life in patients with severe persistent asthma, J ALLERG CL, 106(5), 2000, pp. 852-860
Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects
Authors: Colavita, AM Hastie, AT Musani, AI Pascual, RM Reinach, AJ Lustine, HT Galati, SA Zangrilli, JG Fish, JE Peters, SP
Citation: Am. Colavita et al., Kinetics of IL-10 production after segmental antigen challenge of atopic asthmatic subjects, J ALLERG CL, 106(5), 2000, pp. 880-886
Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils
Authors: Zangrilli, J Robertson, N Shetty, A Wu, J Hastie, A Fish, JE Litwack, G Peters, SP
Citation: J. Zangrilli et al., Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils, CLIN EXP IM, 120(1), 2000, pp. 12-21
Pharmaceutically-based severity stratification of an asthmatic population
Authors: Leone, FT Grana, JR McDermott, P MacPherson, S Hanchak, NA Fish, JE
Citation: Ft. Leone et al., Pharmaceutically-based severity stratification of an asthmatic population, RESP MED, 93(11), 1999, pp. 788-793
Airway remodeling and persistent airway obstruction in asthma
Authors: Fish, JE Peters, SP
Citation: Je. Fish et Sp. Peters, Airway remodeling and persistent airway obstruction in asthma, J ALLERG CL, 104(3), 1999, pp. 509-516
Asthma severity: Histopathologic correlations
Authors: Fish, JE Peters, SB
Citation: Je. Fish et Sb. Peters, Asthma severity: Histopathologic correlations, DRUGS TODAY, 35(8), 1999, pp. 585-594
Prior use of long-acting beta-agonists: Friend or foe in the emergency department?
Authors: Peters, SP Fish, JE
Citation: Sp. Peters et Je. Fish, Prior use of long-acting beta-agonists: Friend or foe in the emergency department?, AM J MED, 107(3), 1999, pp. 283-285
Risultati: 1-16 |